Home 
HOME Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.3, p.179–184, 2016
HOME Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.3, p.179–184, 2016
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.3, p.179–184, 2016 |
||
| Title: HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer | ||
| Author: A. Namvar, A. Bolhassani, M. Hashemi | ||
| Abstract: BACKGROUND: High-risk human papillomavirus (HPV) infections have been associated with the development of cervical cancer. HPV16 is the most dominant high-risk types of HPV worldwide. L1 and L2 are the major and minor capsid proteins of HPV, respectively. Both proteins are able to self-assemble as a virus-like particle (VLP). METHODS: In the current study, the human embryonic kidney cells were transfected with the plasmid DNA encoding HPV 16 L1 or L1–L2 genes and their expression was compared using different transfection reagents. RESULTS: Our data showed that the recombinant L1–L2 DNAs were expressed in a high efficiency compared to L1 DNAs as detected by western blotting, fluorescent microscopy, and flow cytometry. In addition, Lipofectamine and Turbofect as the transfection reagents conferred more potent delivery than PEI 25 kDa indicating high toxicity of this system on HEK-293 cells. These results suggest the use of the full length of L2 as an efficient agent for overcoming the cell barriers and poor uptake of DNA in vitro and in vivo. CONCLUSION: The high expression of HPV16 L1–L2 in HEK-293 cells using different delivery systems opens the way for new studies concerning to the use of L2 for DNA delivery via covalent linkage with the gene of interest (Fig. 5, Ref. 20). |
||
| Keywords: HPV, cervical cancer, L1, L2, lipid and polymeric carriers | ||
| Published online: 24-Feb-2016 | ||
| Year: 2016, Volume: 116, Issue: 3 | Page From: 179, Page To: 184 | |
| doi:10.4149/BLL_2016_034 |
||
|
|
 download file |
|